UBS Group’s Tivity Health, Inc. Common Stock TVTY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-10,003
| Closed | -$322K | – | 11623 |
|
|
2022
Q1 | $322K | Sell |
10,003
-4,643
| -32% | -$126K | ﹤0.01% | 5013 |
|
|
2021
Q4 | $388K | Buy |
14,646
+14,039
| +2,313% | +$357K | ﹤0.01% | 5182 |
|
|
2021
Q3 | $14K | Sell |
607
-227
| -27% | -$5.39K | ﹤0.01% | 7633 |
|
|
2021
Q2 | $22K | Sell |
834
-20,599
| -96% | -$517K | ﹤0.01% | 7257 |
|
|
2021
Q1 | $478K | Sell |
21,433
-4,472
| -17% | -$103K | ﹤0.01% | 4906 |
|
|
2020
Q4 | $507K | Buy |
25,905
+9,103
| +54% | +$151K | ﹤0.01% | 4592 |
|
|
2020
Q3 | $235K | Sell |
16,802
-11,113
| -40% | -$160K | ﹤0.01% | 4705 |
|
|
2020
Q2 | $316K | Sell |
27,915
-7,116
| -20% | -$65K | ﹤0.01% | 4482 |
|
|
2020
Q1 | $221K | Buy |
35,031
+31,684
| +947% | +$511K | ﹤0.01% | 4648 |
|
|
2019
Q4 | $68K | Sell |
3,347
-38,371
| -92% | -$718K | ﹤0.01% | 6198 |
|
|
2019
Q3 | $693K | Buy |
41,718
+18,471
| +79% | +$319K | ﹤0.01% | 4279 |
|
|
2019
Q2 | $382K | Sell |
23,247
-216,616
| -90% | -$4.18M | ﹤0.01% | 4487 |
|
|
2019
Q1 | $4.21M | Buy |
239,863
+134,448
| +128% | +$2.86M | ﹤0.01% | 2347 |
|
|
2018
Q4 | $2.62M | Buy |
105,415
+22,151
| +27% | +$736K | ﹤0.01% | 2764 |
|
|
2018
Q3 | $2.68M | Buy |
83,264
+18,035
| +28% | +$615K | ﹤0.01% | 2944 |
|
|
2018
Q2 | $2.3M | Buy |
65,229
+64,251
| +6,570% | +$2.37M | ﹤0.01% | 3047 |
|
|
2018
Q1 | $39K | Sell |
978
-193,638
| -99% | -$7.52M | ﹤0.01% | 5903 |
|
|
2017
Q4 | $7.11M | Sell |
194,616
-10,751
| -5% | -$408K | ﹤0.01% | 2024 |
|
|
2017
Q3 | $8.38M | Buy |
205,367
+21,288
| +12% | +$825K | ﹤0.01% | 1752 |
|
|
2017
Q2 | $7.34M | Sell |
184,079
-80,777
| -30% | -$2.7M | ﹤0.01% | 1792 |
|
|
2017
Q1 | $7.71M | Sell |
264,856
-8,357
| -3% | -$220K | ﹤0.01% | 1712 |
|
|
2016
Q4 | $6.21M | Buy |
273,213
+45,310
| +20% | +$1.07M | ﹤0.01% | 1897 |
|
|
2016
Q3 | $6.03M | Buy |
227,903
+74,372
| +48% | +$1.5M | ﹤0.01% | 1858 |
|
|
2016
Q2 | $1.77M | Buy |
153,531
+10,934
| +8% | +$128K | ﹤0.01% | 2881 |
|
|
2016
Q1 | $1.44M | Sell |
142,597
-19,042
| -12% | -$214K | ﹤0.01% | 2960 |
|
|
2015
Q4 | $2.08M | Buy |
161,639
+16,778
| +12% | +$204K | ﹤0.01% | 2756 |
|
|
2015
Q3 | $1.61M | Sell |
144,861
-3,213
| -2% | -$39.3K | ﹤0.01% | 2933 |
|
|
2015
Q2 | $1.77M | Sell |
148,074
-10,304
| -7% | -$171K | ﹤0.01% | 3091 |
|
|
2015
Q1 | $3.12M | Buy |
158,378
+308
| +0.2% | +$6.44K | ﹤0.01% | 2514 |
|
|
2014
Q4 | $3.14M | Buy |
+158,070
| New | +$2.58M | ﹤0.01% | 2482 |
|
Other funds holding TVTY
BCMLT
PP
IA
UBS Group's TVTY Position: Q2 2022 in Review
UBS Group sold out of Tivity Health, Inc. Common Stock (TVTY) in Q2 2022, closing a stake of 10,003 shares — an estimated $322K sold.
UBS Group first reported a position in TVTY in Q4 2014 and held it in 30 quarters. The position peaked at $8.38M in Q3 2017. 4 funds tracked by Wall St. Rank hold TVTY as of Q2 2022.
- UBS Group reported no remaining Tivity Health, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
- UBS Group sold 10,003 Tivity Health, Inc. Common Stock shares in Q2 2022, an estimated $322K.
- UBS Group first reported a position in Tivity Health, Inc. Common Stock in Q4 2014 and held it in 30 quarters.
- UBS Group's Tivity Health, Inc. Common Stock position peaked at $8.38M in Q3 2017.
- 4 funds tracked by Wall St. Rank held Tivity Health, Inc. Common Stock as of Q2 2022.
Based on UBS Group's 13F filing for Q2 2022, filed 10 Aug 2022.